We have shown in the present study and our previous report12 that there was a significantly elevated number of CD4+ CD25+ Foxp3+ or CD4+ CD25+ CD127− Tregs in the PBMCs of IBCa patients compared with that in patients with breast benign tumor or healthy women. This evidence concerns the gene FOXP3 and breast benign neoplasm.